News Articles Tagged: COVID-19 Therapies

Exploring the Potential: Nitazoxanide in Hepatitis & COVID-19 Treatment Research

Investigate the emerging research on Nitazoxanide (CAS 55981-09-4) for treating chronic hepatitis and its potential as an early therapeutic for COVID-19.

NINGBO INNO PHARMCHEM CO.,LTD. on the Future of Peptide Therapies: Aviptadil Acetate and Beyond

Discover the significance of Aviptadil Acetate and other VIP peptides in modern therapeutic strategies, as shared by NINGBO INNO PHARMCHEM CO.,LTD., focusing on research and development in pulmonary and systemic health.

Baricitinib Phosphate Intermediate: Enabling Advancements in Rheumatoid Arthritis and COVID-19 Therapies

Discover how Baricitinib Phosphate Intermediate (CAS 1187595-84-1) is instrumental in the development of treatments for rheumatoid arthritis and COVID-19, impacting patient outcomes.